AI assistant
RESMED INC — Director's Dealing 2012
Nov 19, 2012
30071_dirs_2012-11-19_0c73ac06-c147-47bc-bc5a-bc9d5a0fd286.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-11-15
Reporting Person: QUINN MICHAEL A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-15 | ResMed Common Stock Options | $38.98 | A | 25934 | Acquired | 2019-11-15 | ResMed Common Stock (25934) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 302000 | Direct |
| ResMed Common Stock | 400000 | Direct |
| ResMed Common Stock | 66000 | Indirect |
Footnotes
F1: Options vest in full (i) on the first Nov. 11 following grant date or (ii) the first annual shareholder's meeting following grant date. Options have a required holding period until the earlier of (i) Nov. 11 of the third year following grant date or (ii) six months following termination of directorship.
F2: These shares are held as CDIs on the Australian Securities Exchange which represents 24,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.
F3: These shares are held as CDIs on the Australian Securities Exchange which represents 6,600 NYSE shares. 1 NYSE share is equal to 10 CDIs.